Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
FDA-approved test for routine cervical cancer screening in individuals 25 years and older with a cervix.
New York DOH Approval Status
Indicates whether a test has been approved by the New York State Department of Health.
This test is not New York state approved. Alternative testing that is New York approved is available. See Ordering Recommendations.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
Cervical or endocervical specimen with brush or spatula from ThinPrep kit collection kit. (ARUP supply #41785 ThinPrep (Vial and Broom) or #51369 ThinPrep (Vial, Brush, and Spatula)) available online through eSupply using ARUP Connect™ or contact ARUP Client Services at 800-522-2787.
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Place collection device in corresponding ThinPrep media vial.
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
Refrigerated
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
Bloody or dark brown specimens. Specimens in any media other than indicated above.
RemarksAdditional specimen collection, transport, or test submission information.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
Expected turnaround time for a result, beginning when ARUP has received the specimen.
1-5 days If reflexed, add 1-7 days
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Negative
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
This test amplifies DNA of HPV16, HPV18, and 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) associated with cervical cancer and its precursor lesions. Sensitivity may be affected by specimen collection methods, stage of infection, and the presence of interfering substances. Specimens positive for high-risk HPV types are reflexed to cytology. Patients positive for high-risk HPV 16 or HPV 18 should be managed according to current ASCCP guidelines (2019).
Compliance Category
Depends on Specimen/Source/Method
Note
Additional information related to the test.
If HPV assay is positive, then ThinPrep PAP Test (Standalone) (3018968) will be added. Additional charges apply.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
87624; if reflexed add 88175 (88142 if manual); if reviewed by pathologist add 88141
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Connect Sign In
